Last updated: August 18, 2026

Examiner: JACKSON, SHAWQUIA

Tech Center 1600 • Art Units: 1623 1626 1629 1691

This examiner grants 78% of resolved cases

Performance Statistics

77.9%

Allow Rate

+17.9% vs TC avg

1,851

Total Applications

-3.3%

Interview Lift

831

Avg Prosecution Days

Based on 1830 resolved cases, 2023–2026

2.7%

§101 Eligibility

18.1%

§102 Novelty

15.0%

§103 Obviousness

50.7%

§112 Clarity

App #	Title	Status	Assignee
18836191	WATER-SOLUBLE HETEROCYCLYL POLYMETHINE CHROMOPHORES	Non-Final OA	The Regents of the University of California
18897646	KRAS INHIBITORS	Non-Final OA	Eli Lilly and Company
18834987	THIENOPYRROLOTRIAZINE COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE	Non-Final OA	Sanofi
18545711	PROCESS FOR THE PREPARATION OF NLRP3 INHIBITORS	Non-Final OA	Hoffmann-La Roche Inc.
18466489	PROCESS FOR PREPARATION OF IPCONAZOLE & ITS INTERMEDIATES	Final Rejection	UPL Europe LTD

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.